Amr Pharma India Profile
Key Indicators
- Authorised Capital ₹ 12.25 Cr
as on 15-12-2024
- Paid Up Capital ₹ 12.05 Cr
as on 15-12-2024
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 15.90 Cr
as on 15-12-2024
- Revenue 157.82%
(FY 2019)
- Profit -163.74%
(FY 2019)
- Ebitda -760.38%
(FY 2019)
- Net Worth -90.43%
(FY 2019)
- Total Assets -2.26%
(FY 2019)
About Amr Pharma India
The Corporate was formerly known as Mar Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 12.25 Cr and a paid-up capital of Rs 12.05 Cr.
The company currently has active open charges totaling ₹15.90 Cr.
Asaraf Ali, Govindan Ashok, Dharani Vinothkumar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232TN2013PTC091690
- Company No.
091690
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2013
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Amr Pharma India Private Limited offer?
Amr Pharma India Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Content Writing Service, Research Development Services.
Who are the key members and board of directors at Amr Pharma India?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govindan Ashok  | Director | 23-Aug-2013 | Current |
| Asaraf Ali | Director | 23-Aug-2013 | Current |
| Dharani Vinothkumar | Additional Director | 31-Dec-2015 | Current |
| Subramaniam Satish | Additional Director | 01-Feb-2016 | Current |
| Niveditha Latha | Additional Director | 03-Nov-2018 | Current |
Financial Performance of Amr Pharma India.
Amr Pharma India Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 157.82% increase. The company also saw a substantial fall in profitability, with a 163.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 90.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amr Pharma India?
In 2017, Amr Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Molecules Drugs And Research Laboratory Private LimitedActive 15 years 11 monthsAsaraf Ali is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 25 Sep 2015 | ₹1.00 Cr | Open |
Indian Overseas Bank Creation Date: 17 Feb 2014 | ₹14.90 Cr | Open |
How Many Employees Work at Amr Pharma India?
Amr Pharma India has a workforce of 13 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amr Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amr Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
